Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study-Reference-Cited by-同舟云学术

Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study

Published:2013-07 Issue:1-2 Volume:131 Page:112-118
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Dreifuss Jessica A.,Griffin Margaret L.,Frost Katherine,Fitzmaurice Garrett M.,Potter Jennifer Sharpe,Fiellin David A.,Selzer Jeffrey,Hatch-Maillette Mary,Sonne Susan C.,Weiss Roger D.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference68 articles.

1. Prediction of 7 months methadone maintenance treatment response by four measures of antisociality;Alterman;Drug Alcohol Depend.,1998

2. Response to methadone maintenance and counseling in antisocial patients with and without major depression;Alterman;J. Nerv. Ment. Dis.,1996

3. Diagnostic and Statistical Manual of Mental Disorders;American Psychiatric Association,2000

4. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study;Anton;Arch. Gen. Psychiatry,2008

5. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians;Arfken;J. Subst. Abuse Treat.,2010

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of treatment retention rates and predictors of retention on opioid agonist treatment among adolescents;Drug and Alcohol Review;2024-06-17

2. Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder;Drug and Alcohol Dependence Reports;2024-06

3. Cognitive behavioral therapy for anxiety and opioid use disorder: Development and pilot testing;Journal of Substance Use and Addiction Treatment;2024-05

4. Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial;Journal of Dual Diagnosis;2024-04-05

5. Cognitive-Behavioral Therapy for Co-occurring Anxiety and Opioid Use Disorder in People with Chronic Pain;CBT: Science Into Practice;2024